# **Companion Website for "Cell Type Populations for 3D Anatomical Structures of the Human Reference Atlas"**

Andreas Bueckle<sup>1</sup>\*, Bruce W. Herr II<sup>1</sup>\*, Lu Chen<sup>2</sup>, Daniel Bolin<sup>1</sup>, Danial Qaurooni<sup>1</sup>, Michael Ginda<sup>1</sup>, Yashcardhan Jain<sup>1</sup>, Aleix Puig Barbe <sup>3</sup>,Kristin Ardlie<sup>4</sup>, Fusheng Wang<sup>2</sup>, Katy BÃ¶rner<sup>1</sup>\*

<sup>1</sup> Department of Intelligent Systems Engineering, Luddy School of Informatics, Computing, and Engineering, Indiana University, Bloomington, IN 47408, USA \
<sup>2</sup> Department of Computer Science and Department of Biomedical Informatics, Stony Brook University, Stony Brook, 11794, NY, USA \
<sup>3</sup> European Bioinformatics Institute (EMBL-EBI), Wellcome Genome Campus, Hinxton, Cambridge CB10 1SD, UK\
<sup>4</sup> Broad Institute, Cambridge, 02142, MA, USA \
\* Corresponding authors\
[abueckle@iu.edu](mailto:abueckle@iu.edu)\
[bherr@iu.edu](mailto:bherr@iu.edu)\
[katy@iu.edu](katy@iu.edu)
 
The human body contains ~27-36 trillion cells of up to 10,000 cell types (CTs) within a volume of ~62-120 liters (males) and 52-89 liters (females). The Human Reference Atlas (HRA) v2.3 provides a quantitative 3D framework of CTs across 73 reference organs and 1,283 3D anatomical structures (ASs). The HRA Cell Type Population (HRApop) effort has quantified CTs per AS using high-quality single-cell (sc) datasets processed through scalable, reproducible workflows and cell type annotation (CTann) tools. HRApop v1.0 includes reference CT populations for 73 ASs (112 when sex-specific) using 662 datasets spatially registered to 230 locations across 17 organs (31 when sex-specific). For 558 sc-transcriptomics datasets (11,042,750 cells), CTs and biomarker expressions were computed using Azimuth, CellTypist, and popV. To test generalizability, 104 sc-proteomics datasets (16,576,863 cells) were integrated. In total, HRApop includes 27,619,613 cells and serves as a healthy reference for researchers aiming to elucidate mechanisms underlying cellular interactions, FTU operations, and cellular and tissue level disease progression, which may facilitate advancements in basic discovery and lead to new therapeutic strategies.